Cti Biopharm Corp (CTIC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CTIC | ELVN | AUPH | ||
| Company | Cti Biopharm Corp | Enliven Therapeutics Inc | Aurinia Pharm Ord | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 9.10 | 25.59 | 8.31 | ||
| High | 9.10 | 25.76 | 8.76 | ||
| Low | 9.09 | 24.69 | 8.30 | ||
| Last | 9.09 | 25.54 | 8.73 | ||
| Change | unch | +0.11 | +0.49 | ||
| % Change | unch | +0.43% | +5.95% | ||
| Volume | 11,420,900 | 67,125 | 1,817,798 | ||
| 20-Day Average Volume | 3,402,150 | 239,204 | 1,456,402 | ||
| Previous Close | 9.09 | 25.43 | 8.24 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 9.06 | 27.24 | 7.85 | ||
| 20-Day Raw Stochastic | 88.89% | 26.13% | 98.60% | ||
| 20-Day Relative Strength | 80.92% | 43.88% | 68.84% | ||
| Weighted Alpha | +5.50 | +35.75 | +32.11 | ||
| Today's Opinion | 100% Buy | 56% Buy | 100% Buy | ||
| Previous Opinion | 100% Buy | 56% Buy | 100% Buy | ||
| Last Month's Opinion | 48% Buy | 100% Buy | 80% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.22% since 06/15/23 | +1.48% since 11/14/24 | +4.69% since 11/14/24 | ||
| Low | 9.07 on 06/20/23 | 23.70 on 11/15/24 | 7.87 on 11/18/24 | ||
| High | 9.10 on 06/23/23 | 26.48 on 11/20/24 | 8.74 on 11/21/24 | ||
| 1-Month | |||||
| %Chg | +1.11% since 05/23/23 | -12.40% since 10/21/24 | +21.63% since 10/21/24 | ||
| Low | 8.98 on 05/24/23 | 23.70 on 11/15/24 | 6.85 on 10/23/24 | ||
| High | 9.10 on 06/23/23 | 29.78 on 11/07/24 | 8.74 on 11/21/24 | ||
| 3-Month | |||||
| %Chg | +111.40% since 03/23/23 | +6.84% since 08/21/24 | +32.33% since 08/21/24 | ||
| Low | 4.01 on 04/06/23 | 21.34 on 08/30/24 | 6.42 on 09/11/24 | ||
| High | 9.10 on 06/23/23 | 30.03 on 10/18/24 | 8.74 on 11/21/24 | ||
| 6-Month | |||||
| %Chg | +61.46% since 12/23/22 | +10.44% since 05/21/24 | +56.00% since 05/21/24 | ||
| Low | 4.01 on 04/06/23 | 19.52 on 06/07/24 | 5.11 on 05/29/24 | ||
| High | 9.10 on 06/23/23 | 30.03 on 10/18/24 | 8.74 on 11/21/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 1,198,789 | 1,242,485 | 1,179,795 | ||
| Shares Outstanding, K | 131,880 | 48,859 | 143,179 | ||
| Annual Sales | 53,950,000 | 0 | 175,510,000 | ||
| Annual Net Income | -92,990,000 | -71,580,000 | -78,020,000 | ||
| Last Quarter Sales | 24,120,000 | 0 | 67,770,000 | ||
| Last Quarter Net Income | -13,420,000 | -23,160,000 | 14,350,000 | ||
| 60-Month Beta | 0.83 | 1.08 | 1.45 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.10 on 05/15/23 | -0.48 on 11/13/24 | 0.10 on 11/07/24 | ||
| Latest Earnings Date | 08/14/23 | 11/14/24 | 11/07/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||